Work

Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity

Year: 2012

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccr.2012.06.028

Authors: Rodrigo Leite de Oliveira, Sofie Deschoemaeker, Anne-Theres Henze, Koen Debackere, Veronica Finisguerra, Yukiji Takeda, Carmen Roncal, Daniela Dettori, Evelyne Tack, Yannick Jönsson, Lorenzo Veschini, Annelies Peeters, Andrey Anisimov, Matthias Hofmann, Kari Alitalo, Myriam Baes, Jan D'hooge, Peter Carmeliet, Massimiliano Mazzone

Institutions: KU Leuven, Centro de Investigación Médica Aplicada, Universidad de Navarra, Institute for Molecular Medicine Finland, Goethe University Frankfurt

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Helsingin Yliopisto, Fonds Wetenschappelijk Onderzoek, Stichting Tegen Kanker

Awards: G4661664446, Targeting PHD2 oxygen sensor: novel and promising avenue to optimize chemo- and radiotherapy in cancer.

OpenAlex ID: W2061995133

FWCI: 4.977

Cites: 58

Cited by: 125

Related to: 10